Q3 2015 Holdings
Filed 2015-11-10 | 9 holdings | $146.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Trevena, Inc. | Common Stock | 89532E109 | $27.6K | 2,669,280 | 18.8% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $18.8K | 1,827,992 | 12.8% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $17.7K | 3,607,996 | 12.1% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $17.7K | 2,018,450 | 12.0% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $17.3K | 1,230,009 | 11.8% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $13.5K | 1,968,606 | 9.2% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $13.2K | 2,473,186 | 9.0% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $12.0K | 3,287,529 | 8.2% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $9.0K | 2,018,253 | 6.1% |